Skip to main content
Premium Trial:

Request an Annual Quote

All Things Open Access

Open-access proponents got good news this week. For starters, the Ontario Institute for Cancer Research announced that it will make all of the research it funds publicly available. (You can check out the press release here for more details and a very nice photo of Francis Ouellette.)

Also, Elsevier released some information about its Article 2.0 Contest, in which the company is making 7,500 scientific articles openly accessible and asking contestants to come up with a new publishing model for them. "The contestant becomes the publisher and can render scientific articles to meet their needs including integrating the article into existing applications or combining it with other web service APIs," according to Elsevier. The contest officially starts on Sept. 1, and first prize is $2,500.

 

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.